VeriMomnaringenin hamilelikte güvenli mi?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
Pregnancy-safe products containing naringenin
Related ingredients
Frequently asked questions
- naringenin hamilelikte güvenli mi?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
- naringenin emzirirken güvenli mi?
- Same rationale as for pregnancy: no harmonised reproductive classification and no authoritative CIR/SCCS contraindication identified. Potential for low systemic absorption after topical use implies low measurable exposure in breastfeeding parent (e=1). No specific data on milk transfer were found in the authoritative sources consulted.
- naringenin bebek cildi için güvenli mi?
- No infant‑specific developmental toxicity or dermal‑toxicity data indicating increased hazard. Following the specified instruction to increase exposure for infants when adult topical absorption is measurable, baby exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher permeability and greater surface‑area‑to‑weight ratio. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- VeriMom naringenin nasıl puanlıyor?
- VeriMom naringenin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte naringenin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.